What does PHARMACIE DEFRE do?

PHARMACIE DEFRE is a logistics company in Celles (lez-Tournai). Private Limited, started on 14 April 2003, 1 establishment.

What is the address of PHARMACIE DEFRE?

The registered office of PHARMACIE DEFRE is located at Place de Velaines (VEL) 13, 7760 Celles (lez-Tournai).

Is PHARMACIE DEFRE still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DEFRE is active, legal situation “Normale toestand”, started on 14 April 2003.

Is PHARMACIE DEFRE registered on Peppol?

Yes, PHARMACIE DEFRE is registered on the Peppol network with ID 0208:0480024492.

What is the enterprise number of PHARMACIE DEFRE?

The enterprise number of PHARMACIE DEFRE is BE0480024492.

When was PHARMACIE DEFRE founded?

PHARMACIE DEFRE was founded on 14 April 2003.

Who are the directors of PHARMACIE DEFRE?

According to the 2025 annual accounts, the directors of PHARMACIE DEFRE are: BLUESTONE SRL.

Is PHARMACIE DEFRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 April 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DEFRE make in 2025?

PHARMACIE DEFRE posted a profit after taxes of € 72,183 in financial year 2025.

What is the revenue of PHARMACIE DEFRE?

As a small company, PHARMACIE DEFRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 350,376.

How much does an employee at PHARMACIE DEFRE earn?

The average wage cost per full-time employee at PHARMACIE DEFRE was € 87,200 in 2025: staff costs of € 200,479 for 2.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DEFRE have?

According to the 2025 annual accounts, PHARMACIE DEFRE has 2.3 full-time equivalents (FTE).

PHARMACIE DEFRE (Private Limited) - Celles (lez-Tournai)

Dossier PHARMACIE DEFRE, printed on 30 October 2026 from databakkes.be/en/0480024492/pharmacie-defre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DEFRE from Celles (lez-Tournai), company number BE0480024492, closed financial year 2025 with a result of € 72,183 after tax. For that financial year PHARMACIE DEFRE recorded a gross margin of € 350,376 and equity of € 353,809. Compared with financial year 2024, the result moved from € 58,682 to € 72,183. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 353,809

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 72,183

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 83,207

▲ 147% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

69 % of the profit went to the shareholders, mostly to LES PHARMACIES RURALES (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.3

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 200,479

▲ 20% vs 2024

€ 87,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,707

▼ 57% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 221,310

▼ 17% vs 2024

€ 47,822 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 414,282

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 46,930

▼ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 376,090 Gross margin 2022: € 376,090 First fiscal year in the series	€ 347,372 Gross margin 2023: € 347,372 ▼ 8% vs 2022 (€ 376,090) Unfavourable step	€ 303,812 Gross margin 2024: € 303,812 ▼ 13% vs 2023 (€ 347,372) Unfavourable step	€ 350,376 Gross margin 2025: € 350,376 ▲ 15% vs 2024 (€ 303,812) Favourable step	▲ 15%
Profit after taxes	€ 116,635 Profit after taxes 2022: € 116,635 First fiscal year in the series	€ 65,336 Profit after taxes 2023: € 65,336 ▼ 44% vs 2022 (€ 116,635) Unfavourable step	€ 58,682 Profit after taxes 2024: € 58,682 ▼ 10% vs 2023 (€ 65,336) Unfavourable step	€ 72,183 Profit after taxes 2025: € 72,183 ▲ 23% vs 2024 (€ 58,682) Favourable step	▲ 23%
Equity	€ 262,607 Equity 2022: € 262,607 First fiscal year in the series	€ 307,943 Equity 2023: € 307,943 ▲ 17% vs 2022 (€ 262,607) Favourable step	€ 331,625 Equity 2024: € 331,625 ▲ 8% vs 2023 (€ 307,943) Favourable step	€ 353,809 Equity 2025: € 353,809 ▲ 7% vs 2024 (€ 331,625) Favourable step	▲ 7%
Total debts	€ 962,820 Total debts 2022: € 962,820 First fiscal year in the series	€ 878,842 Total debts 2023: € 878,842 ▼ 9% vs 2022 (€ 962,820) Favourable step	€ 819,509 Total debts 2024: € 819,509 ▼ 7% vs 2023 (€ 878,842) Favourable step	€ 803,243 Total debts 2025: € 803,243 ▼ 2% vs 2024 (€ 819,509) Favourable step	▼ 2%
Cash	€ 100,206 Cash 2022: € 100,206 First fiscal year in the series	€ 34,115 Cash 2023: € 34,115 ▼ 66% vs 2022 (€ 100,206) Unfavourable step	€ 33,682 Cash 2024: € 33,682 ▼ 1% vs 2023 (€ 34,115) Unfavourable step	€ 83,207 Cash 2025: € 83,207 ▲ 147% vs 2024 (€ 33,682) Favourable step	▲ 147%
Land & buildings	€ 346,988 Land & buildings 2022: € 346,988 First fiscal year in the series	€ 319,217 Land & buildings 2023: € 319,217 ▼ 8% vs 2022 (€ 346,988) Unchanged	€ 291,445 Land & buildings 2024: € 291,445 ▼ 9% vs 2023 (€ 319,217) Unchanged	€ 263,674 Land & buildings 2025: € 263,674 ▼ 10% vs 2024 (€ 291,445) Unchanged	▼ 10%
Retained profit	€ 212,607 Retained profit 2022: € 212,607 First fiscal year in the series	€ 257,943 Retained profit 2023: € 257,943 ▲ 21% vs 2022 (€ 212,607) Favourable step	€ 281,625 Retained profit 2024: € 281,625 ▲ 9% vs 2023 (€ 257,943) Favourable step	€ 303,809 Retained profit 2025: € 303,809 ▲ 8% vs 2024 (€ 281,625) Favourable step	▲ 8%
Dividend	€ 60,000 Dividend 2022: € 60,000 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 ▼ 67% vs 2022 (€ 60,000) Unchanged	€ 35,000 Dividend 2024: € 35,000 ▲ 75% vs 2023 (€ 20,000) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▲ 43% vs 2024 (€ 35,000) Unchanged	▲ 43%
Bank debt	€ 348,078 Bank debt 2022: € 348,078 First fiscal year in the series	€ 305,557 Bank debt 2023: € 305,557 ▼ 12% vs 2022 (€ 348,078) Favourable step	€ 265,345 Bank debt 2024: € 265,345 ▼ 13% vs 2023 (€ 305,557) Favourable step	€ 221,310 Bank debt 2025: € 221,310 ▼ 17% vs 2024 (€ 265,345) Favourable step	▼ 17%
Balance sheet total	€ 1,225,426 Balance sheet total 2022: € 1,225,426 First fiscal year in the series	€ 1,186,785 Balance sheet total 2023: € 1,186,785 ▼ 3% vs 2022 (€ 1,225,426) Unchanged	€ 1,151,134 Balance sheet total 2024: € 1,151,134 ▼ 3% vs 2023 (€ 1,186,785) Unchanged	€ 1,157,052 Balance sheet total 2025: € 1,157,052 ▲ 1% vs 2024 (€ 1,151,134) Unchanged	▲ 1%
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▼ 0.1 vs 2022 (2.5) Unchanged	2.3 Employees (FTE) 2024: 2.3 ▼ 0.1 vs 2023 (2.4) Unchanged	2.3 Employees (FTE) 2025: 2.3 Unchanged (2.3) Unchanged

Key figures of PHARMACIE DEFRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DEFRE?

What happened at PHARMACIE DEFRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 72,183 (▲ 23% vs 2024). filed late Source: NBB ↗
2022 BLUESTONE SRL became a director. NBB
May 16, 2003 New establishment in Ukkel. KBO
Apr 14, 2003 Start of the company according to the CBE. KBO

In short

From € 116,635 profit in 2022 to € 72,183 profit in 2025.

Paid € 60,441 in corporate taxes since 2022.

Best year ever: 2022, with € 116,635 profit.

On average € 152,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

LES PHARMACIES RURALES 100%

The stake of LES PHARMACIES RURALES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DEFRE

PHARMACIE DU PESAGE SA 21%

PHARMIMPULSE GIE 6.7%

Behind PHARMACIE DEFRE is BLUESTONE SRL. The shares are held by LES PHARMACIES RURALES (100%). It owns 21% of PHARMACIE DU PESAGE SA and 6.7% of PHARMIMPULSE GIE itself.

Directors

According to the 2025 annual accounts

BLUESTONE SRL

Director · represented by Paul RANSART

Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, ANCIAUX, DIGITALE, DELTAPHAR +6 more

since 2022

Shareholders

LES PHARMACIES RURALES

100%

Participations

PHARMACIE DU PESAGE SA

21%

PHARMIMPULSE GIE

6.7%

Establishments

Establishment units

Physical locations of this company

Registered office

Place de Velaines (VEL) 13

7760 Celles (lez-Tournai)

2.131.765.040

De Frélaan 179

1180 Ukkel

Active since 16 May 2003

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

LES PHARMACIES RURALES same network

€ 1.5 million gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0480.024.492

VAT number

BE 0480.024.492

Registered office

Place de Velaines (VEL) 13, 7760 Celles (lez-Tournai)

Names & denominations

PHARMACIE DEFRE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 April 2003

Peppol

Active · Active since 20 Oct 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DEFRE

Financials

What happened to PHARMACIE DEFRE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions